The STEP (Semaglutide Treatment Effect in People with obesity) trial program showed that participants using semaglutide 2.4 mg weekly achieved an average weight loss of 12-15% of their initial body weight over 68 weeks, compared to 2-3% with placebo
Pyridoxine: Can decrease the effectiveness of Vitamin B6
Vitamin B12 deficiency, also known as cobalamin deficiency, is a condition that occurs when there is an insufficient amount of vitamin B12 in the body
The eight registrational trials cover: TRIUMPH-1 General obesity, 80 wk (Q2 2026 readout) TRIUMPH-2 Obesity with type 2 diabetes (89 wk
No extras, like promotional materials, branded swag, or nausea medication, were included
Retatrutide is a synthetic research peptide currently being studied for its multi-receptor activity in controlled laboratory environments